Since 1995, Reliable Business Intelligence for Clinical Laboratories, Pathology Groups and Laboratory Diagnostics

IVD Companies Launch New Assays, Analyzers, Automation

Quarterly earnings reports show COVID-19 test revenue continues its steep decline for IVD firms

Steep declines in SARS-CoV-2 test revenue were reported by the top in vitro diagnostics (IVD) companies in Q2 2023 earnings compared to a year earlier. For some of those firms, the coronavirus testing drops equate to billions of dollars in lost revenue. In response to the decreasing demand for COVID-19 testing, IVD manufacturers are scrambling …

IVD Companies Launch New Assays, Analyzers, Automation Read More »

To access this post, you must purchase The Dark Report.



You are reading premium content from The Dark Report, your primary resource for running an efficient and profitable laboratory.

Get Unlimited Access to The Dark Report absolutely FREE!

You have read 0 of 1 of your complimentary articles this month

Privacy Policy: We will never share your personal information.